Clinical Trial Update: Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of early antifibrotic therapy for non-progressive fibrotic interstitial lung disease. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrotic Interstitial Lung Disease

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Fibrotic Interstitial Lung Disease | Phase 4 | Status: NOT_YET_RECRUITING